Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system
Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system in early April into the U.S. endovascular market. Voyager includes an automated syringe operated by a button-operated device called AngioTouch and a touchscreen display that lets the physician tailor injections at the patient’s side.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.